Well this incidence doesn't describe the nature of the email I received, though both situations are examples of abuse;
this post would/might benefit some newbies, of course, if they are like me, they'll choose to learn the hard way (positive part of learning the hard way is, one tends to learn quicker!
But, anyway, good post and thanks for re-posting!
I'm trying to get in through www.financialchat.com is there another way to the room. financialchat not loading at the moment.
DROOY penny play on gold spike,Dollar tank. Stock has not particiapted in gold run (its a turd) BUT every turd has its day and this chart says the risk/reward here is attractive now at $1.14-15. 1st target and breakout is $1.25. Support $1.10.
HAWK to $16 imo...
i HATE paltalk - had major pc issues last time i used
ya, always good to have a back up place though
buying ICGN at .75
icgn trading below cash at .76 cents way to cheap listen to the cc they are working with the fda on the trial where the stock got hit earlier in the year , small float 17m for a bio stock
PRODUCT PIPELINE http://www.icagen.com/about/productpipeline.html
The Companyâ€™s four most advanced programs are:
ICA-17043 for sickle cell disease, for which the Company is conducting a Phase III clinical trial;
lead compounds for epilepsy and neuropathic pain, for which the Company is conducting preclinical studies;
a compound for atrial fibrillation, for which the Companyâ€™s collaborator Bristol-Myers Squibb Company is conducting preclinical studies; and
lead compounds for dementia, including Alzheimerâ€™s disease, for which the Companyâ€™s collaborator Astellas Pharma Inc. is conducting preclinical studies, and lead compounds for attention deficit/hyperactivity disorder, which were derived from the collaboration and for which the Company is conducting preclinical studies.
Icagen is also conducting ongoing drug discovery programs focused on new therapeutics for pain disorders, inflammatory disorders and glaucoma.
Govt may vaccinate children against bug
Email Print Normal font Large font November 9, 2006 - 6:29PM
AdvertisementAll Australian children will be vaccinated against the potentially deadly rotavirus under a plan being considered by the federal government.
The government's drug advisory committee has recommended two vaccines - RotaTeq and Rotarix - be funded as a universal mass vaccination for infants against the common gastro disease.
If approved, all children would be vaccinated in either two or three doses before they are six-months-old.
A health department spokesperson confirmed the Pharmaceutical Benefits Advisory Committee (PBAC) had recommended both vaccines to be included on the Australian National Immunisations Program Schedule in 2007 at a meeting early this month.
This will allow state-based providers to roll-out the program before the next winter seasonal peak for rotavirus, a disease that hospitalises 10,000 Australian children each year.
The move has been applauded by Professor Graeme Barnes, a specialist at the Murdoch Children's Research Institute at the Royal Children's Hospital in Melbourne.
"This is just fantastic, brilliant news, of course on the assumption that the government will act on the recommendation," Prof Barnes said.
"I'm pretty hopeful of that though - and if it does it's going to help so many kids, so that's just great."
insm contract on october 30 has never been pr by insm link to the 7.5 million contract
October 30, 2006
Agency: Department of Veterans Affairs
Office: VA National Acquisition Center
Location: Department of Veterans Affairs National Acquisition Center
Posted: October 30, 2006
Title: 65--65 -- 65 I B
Award Number: V797P-5906X (Archived)
Document Type: Award Notice
Posted Date: Oct 30, 2006
Archive Date: Oct 30, 2006
Classification Code: 65 -- Medical, dental & veterinary equipment & supplies
Naics Code: N/A
Contracting Office Address
Attn: Department of Veterans Affairs National Acquisition Center, (049A1), P.O. Box 76, Building No. 37, Hines, Illinois 60141
Contract Award Date: Jun 09, 2006
Contract Award Number: V797P-5906X
Contract Award Amount: $7,500,000
Contract Line Item Number:
Contractor: Insmed Incorporated, 4851 Lake Brook Dr., Glen Allen, Virginia, 23060
CMGI chart is looking better and better IMHO. Anyone is playing this too, not only for swing trading, but for a longer term?
good news for INSM
Insmed Provides Update Concerning Virginia Unfair Competition Litigation
PrintE-mailDisable live quotesRSSDigg itDel.icio.usLast Update: 6:42 PM ET Oct 4, 2006
RICHMOND, Va., Oct 04, 2006 /PRNewswire via COMTEX/ -- Insmed Incorporated announced today that the U.S. District Court for the Eastern District of Virginia granted in part Insmed's motion to dismiss unfair competition claims brought against Insmed by Tercica, Inc. In a ruling today, Chief United States District Judge James R. Spencer narrowed the scope of Tercica's lawsuit against Insmed. In dismissing portions of the claims brought by Tercica, the Court found areas in which Tercica had not met its burden of establishing that the alleged statements made by Insmed constituted "false advertising" or violated Virginia law. While the court held that a number of Tercica's other factual allegations, if proven, would state claims for false advertising under federal and California law, in comments at the September 9 hearing, Judge Spencer noted that he felt "most if not all" of Tercica's case "could go out on summary judgment."
IPLEX is approved in the United States as the only once daily treatment for children with short stature associated with severe primary IGF-I deficiency (Primary IGFD). IPLEX, a complex of recombinant human IGF-I and its binding protein IGFBP-3 (rhIGF-I/rhIGFBP-3), is the only FDA-approved IGF- I replacement therapy that also replaces deficient IGFBP-3 in these patients. The drug, which was launched in the second quarter of 2006, is also being investigated for various other indications with unmet medical needs, including severe insulin resistance, myotonic muscular dystrophy and HIV Associated Adipose Redistribution Syndrome (HARS). For more information about IPLEX please go to http://www.go-IPLEX.com.